Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

397
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
397
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

143
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143
Data Collection I01:30

Data Collection I

7.8K
Data collection gathers information needed to make accurate judgments about a patient's present condition. During a health history interview, subjective data is collected from the patient, their caregivers, or family members, and objective data is collected through observations and physical assessment. Patients are the primary source of subjective data. Thus information gathered from patients through interviews, observations, and physical examination is primary data. Secondary sources of...
7.8K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

200
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
200

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells.

bioRxiv : the preprint server for biology·2026
Same author

Profiling of Both Dipeptidyl Peptidase III and Renin Reveals Higher Mortality in Septic Shock.

Research square·2026
Same author

WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design.

NPJ breast cancer·2026
Same author

An improved analytic workflow for serum mtDNA DAMP abundance, fragmentation and heteroplasmic variants: a retrospective analysis of acute respiratory failure patients.

Scientific reports·2026
Same author

Biological subphenotypes in severe acute hypoxaemic respiratory failure and acute respiratory distress syndrome using rapid prospective classification (SPARC) in the USA: a multicentre, observational, study.

The Lancet. Respiratory medicine·2026
Same author

Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer.

European urology focus·2026
Same journal

Integrative proteogenomic analyses identify plasma proteins that impact the risk of ischemic stroke.

Communications medicine·2026
Same journal

A memory retrieval-aversive conditioning procedure durably reduces gaming craving and fronto-insular activation in internet gaming disorder: a randomized controlled trial.

Communications medicine·2026
Same journal

Intraoperative dexmedetomidine reduces postoperative sleep disturbance in older adults undergoing major abdominal surgery: a single-center, randomized, double-blind, placebo-controlled trial.

Communications medicine·2026
Same journal

The landscape of artificial intelligence in neurodegenerative diseases: a systematic review.

Communications medicine·2026
Same journal

Troponin release and mechanism-dependent myocardial injury in a lightning-induced mass casualty incident.

Communications medicine·2026
Same journal

Integrating a national crisis counseling hotline into Iran's primary health care network to provide rapid mental health support during armed conflict.

Communications medicine·2026
查看所有相关文章

相关实验视频

Updated: Jan 13, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K

系统的数据采集减少了对源数据验证的需求:从第二阶段多中心随机控制平台试验的探索性分析.

Ali B Abbasi1, Kathleen D Liu1, Derek W Russell2

  • 1University of California San Francisco, San Francisco, CA, USA.

Communications medicine
|October 30, 2025
PubMed
概括
此摘要是机器生成的。

在临床试验中,源数据验证 (SDV) 通常是不必要的. 一个COVID-19试验发现,系统的数据捕获和监控,没有SDV,保持数据完整性和提高效率.

更多相关视频

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

806
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.7K

相关实验视频

Last Updated: Jan 13, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

806
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.7K

科学领域:

  • 临床试验 临床试验
  • 数据管理数据管理
  • 流行病学 流行病学

背景情况:

  • 由于COVID-19大流行,需要进行临床试验,进行强大的初级数据采集,减少对源数据验证 (SDV) 的依赖.
  • 本研究评估了一项自然实验,将简化数据采集方法与传统的SDV进行比较.

研究的目的:

  • 在大型COVID-19临床试验中,评估系统数据采集与传统SDV的质量,成本和影响.
  • 确定消除SDV是否会影响数据完整性和试验结果.

主要方法:

  • 在I-SPY COVID平台试验 (NCT04488081) 中,使用了日常检查清单,实验室/药物捕获和集中监控,而不是SDV.
  • 在临床试验结束后,对30%的患者 (333/1,111) 和23%的电子病例报告表 (eCRF) 进行了回顾性SDV.

主要成果:

  • 追溯SDV导致微小的数据场变化 (0.36%) 并没有改变记录的结果 (死亡,恢复,审查).
  • SDV发现了另外两个不良事件,并将9个病例的恢复日期推移了2天的中位数.
  • 23%的eCRF的回顾性SDV产生了相当大的成本:61,073人小时和610万美元.

结论:

  • 广泛的SDV没有改变I-SPY COVID试验的结果或结论.
  • 该试验的系统数据采集和监测策略被证明是有效的,这表明SDV可能可以在类似的试验中消除.
  • 这种方法有可能提高临床试验的效率并降低成本.